Camnus, Rhea Mae B.

HRN: 28-19-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2026
02/09/2026
IVT
500mg
Q 8
Tmsaf
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: